SPON1 Antikörper (AA 247-611)
Kurzübersicht für SPON1 Antikörper (AA 247-611) (ABIN7825866)
Target
Alle SPON1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 247-611
-
Verwendungszweck
- Anti-SPON1 Antibody
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Produktmerkmale
- Anti-SPON1 Antibody catalog # A03094-1. Tested in IHC, ELISA applications. This antibody reacts with Human.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human SPON1 recombinant protein (Position: E247-H611). Human SPON1 shares 97.8% and 97.5% amino acid (aa) sequence identity with mouse and rat SPON1, respectively.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry, 2-5 μg/mL, Human
ELISA, 0.1-0.5 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Konzentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
-
-
- SPON1 (Spondin 1 (SPON1))
-
Andere Bezeichnung
- SPON1
-
Hintergrund
- Predicted to enable LBD domain binding activity and metal ion binding activity. Predicted to be an extracellular matrix structural constituent. Predicted to be involved in cell adhesion. Predicted to act upstream of or within negative regulation of amyloid-beta formation, positive regulation of amyloid precursor protein catabolic process, and positive regulation of protein processing. Located in extracellular space.
-
Gen-ID
- 10418
Target
-